PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

Market Cap	6.26B +73.6%
Revenue (ttm)	691.21M +18.5%
Net Income	46.10M +81.6%
EPS	0.32 +70.7%
Shares Out	137.54M
PE Ratio	142.69
Forward PE	n/a
Dividend	0.50 (1.13%)
Ex-Dividend Date	Jan 13, 2026

Volume	13,984,287
Average Volume	9,197,319
Open	44.00
Previous Close	44.40
Day's Range	43.42 - 45.78
52-Week Range	28.90 - 67.97
Beta	1.05
RSI	61.89
Earnings Date	Apr 29, 2026

About SHE:301230

PharmaResources (Shanghai) Co., Ltd. engages in new drug research, development, and commercial production in China. It offers small molecule drug CRO, CDMO, and CMO. The company also involved in drug discovery, research, and development of pharmaceutical processes; and customized and commercial production of APIs, and key intermediates. It serves global pharmaceutical and biotechnology companies. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,085
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301230

Financial Performance

In 2025, SHE:301230's revenue was 688.35 million, an increase of 26.43% compared to the previous year's 544.47 million. Earnings were 34.29 million, an increase of 100.75%.